Vimarsana
Biggest News Aggregation in the World

Page 29 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine - Vimarsana News

Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Guest Editorial Week Of 11/22/2021 - Vimarsana News

Guest Editorial Week Of 11/22/2021

Dr. Fauci warned about coronaviruses in 2003 but didn’t act on it

Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine - Vimarsana News

Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine

Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine - read this article along with other careers information, tips and advice on BioSpace

Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine - Vimarsana News

Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Thermostable Vaccine Technology Platform to be Presented at the 6th International Conference on Vaccines Research and Development - Vimarsana News

Thermostable Vaccine Technology Platform to be Presented at the 6th International Conference on Vaccines Research and Development

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...